TriSol Medical

Percutaneous Tricuspid Valve Replacement

Health Tech & Life Sciences
Active
Series A Yokne'am Illit Founded 2016
Total raised
$31.4M
Last: Undisclosed 2023-07
Stage
Series A
Founded
2016
Headcount
25
HQ
Yokne'am Illit
Sector
Health Tech & Life Sciences

About

Trisol Medical goal is to develop the best-in-class Transcatheter Tricuspid Replacement Valve, which eliminates Tricuspid Regurgitation while preserving the Right Ventricle function. Trisol Medical device concept and unique design was created out of deep understanding and knowledge of the unmet need of treating Tricuspid Valve insufficiency.

Trisol device is a Transcatheter Tricuspid Valve Replacement, which is implanted easily and intuitively. Trisol valve is constructed out of nitinol frame with specially designed dome-shaped leaflet. Its unique design provides a comprehensive solution to eliminating Tricuspid Regurgitation while preserving the Right Ventricle function. Trisol Valve is suited to all severe Tricuspid Regurgitation patients.

Funding history · 3 rounds · $31.4M total

2023-07
Undisclosed $1.4M
2018-10
Series A $2.7M
Date unknown
Seed Undisclosed

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

valvescardiologycardiovascularmedical-deviceshospitals